ORIONS Money Stocks

[oldberkeley]

Re DVAX, some possible strategies: Currently at $3.25. William Blair analysts just predicted a limited approval on Feb. 24 with a price target of $5.

http://seekingalpha.com/article/1109311-william-blair-analysts-are-gaining-comfort-ahead-of-dynavax-s-heplisav-pdufa

IMHO, FWIW: one month run-up to at least $4 is likely, so it's a darn good trade from here. At that point, I’d have my finger on the trigger. Would not hold through PDUFA! If limited approval, sell that day ($4.50 - $5 ???). If no approval, it’ll drop but not drastically (that already happened after the November ADCOMM meeting) probably to the high $2’s.

At that price it would be a great longer-term hold, because after one more safety study it should be fully approved in 2014, target $8 - $10.